Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Sees Significant Decrease in Short Interest
MarketBeat
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX - Get Free Report) saw a significant decrease in short interest in July. As of July 15th, there was short interest totaling 6,212,042 shares, a decrease of 55.1% from the June 30th total of 13,845,220 shares. Based on an average daily volume of 13,437,117 shares, the short-interest ratio is currently 0.5 days. Approximately 6.1% of the shares of the stock are short sold.
NASDAQ:CRNX
